
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
[ Wed, Nov 01st 2023 ]: WOPRAI
Eric Joseph Maintained (TGTX) at Buy with Increased Target to $23 on, Nov 1st, 2023


🞛 This publication is a summary or evaluation of another publication
Eric Joseph of JP Morgan, Maintained "TG Therapeutics, Inc." (TGTX) at Buy with Increased Target from $22 to $23 on, Nov 1st, 2023.
Eric has made no other calls on TGTX in the last 4 months.
There are 3 other peers that have a rating on TGTX. Out of the 3 peers that are also analyzing TGTX, 1 agrees with Eric's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Corinne Jenkins of "Goldman Sachs" Maintained at Hold with Decreased Target to $12 on, Thursday, August 3rd, 2023
These are the ratings of the 2 analyists that currently disagree with Eric
- Mayank Mamtani of "B. Riley Securities" Maintained at Strong Buy with Decreased Target to $24 on, Friday, October 20th, 2023
- Edward White of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $41 on, Monday, September 18th, 2023